InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Kraus Carl N, Chief Medical Officer. Officer active across 1 company, notably Aquestive Therapeutics, Inc.. In total, 7 filings have been published. Split: 0 buy · 2 sells. Total volume traded: €244k. Activity tracked since 9 August 2023. The latest transaction was disclosed on 15 October 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
20,272 shares@ US$7.000.015% mcap50.0% of flowCommon StockSEC:0001214659-25-015047:0
20,272 shares@ US$7.0050.0% of flowCommon StockSEC:0001214659-25-015047
10,819 shares@ US$3.9011.5% of flowCommon StockSEC:0001214659-25-011823:0
70,000 shares0Common StockSEC:0001214659-25-004225:0
10,819 shares@ US$3.4310.8% of flowCommon StockSEC:0001214659-24-014226:0
112,500 shares0Common StockSEC:0001214659-24-004306:0
150,000 shares0Common StockSEC:0001214659-23-010919:0
7 of 7 declarations
About Kraus Carl N
Kraus Carl N is the Chief Medical Officer of Aquestive Therapeutics, Inc. He is responsible for the medical strategy and clinical development of the company, which focuses on innovative treatments. His role is essential in ensuring that Aquestive's products meet safety and efficacy standards.
